A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms
暂无分享,去创建一个
H. Stockinger | M. Kundi | M. Farcet | T. Kreil | U. Wiedermann | U. Scheikl | A. Wagner | J. Jasińska | E. Hoeltl | I. Zwazl | J. Ruff | A. Guzek